Global Acne Drug Market Report 2021-2022 and 2030 with Almirall, Bausch, Galderma, Mayne Pharma, GlaxoSmithKline, Mylan, Pfizer, Johnson & Johnson, Sun Pharma and Teva

DUBLIN, October 14, 2022 /PRNewswire/ — The report “Acne Drugs Market by Therapeutic Class, Formulation, Type, Acne Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2022-2030” has been added. at from offer.

Research and Markets Logo

With an estimated value of over $10.08 billion in 2021, the global acne medication market is expected to flourish at a CAGR of 3.4% and valued at over $14.26 billion over the forecast year 2022-2030

Acne is the most common skin condition, usually caused by structural changes in the skin. It affects nearly millions of adolescents worldwide.

Therefore, there is a huge demand for topical and oral acne medications. Topical medications include creams, gels, and ointments made with retinoids, benzoyl peroxide, salicylic acid, and others. On the other hand, oral acne medications are relatively more effective when moderate to severe acne does not respond to topical agents.

Market dynamics and trends

Numerous factors such as changing hormone levels, increasing adolescent population, and growing adoption of skincare products are significantly driving the growth of the global acne medication market. Moreover, excessive production of oil by sebaceous glands and unsanitary lifestyle cause the occurrence of acne, which has a positive impact on the growth of the market.

However, the side effects such as skin irritation, dry skin, and erythema or redness of the skin due to the use of acne medications are expected to hamper the market growth.

On the contrary, increasing R&D in skincare along with high market potential in untapped emerging countries is expected to be opportunistic for market growth. Additionally, the increasing frequency and severity of acne is one of the major factors that will drive the market size over the forecast period.

Geographical analysis

In terms of geography, North America held a major share of the market in 2020. This is attributed to the rise in the use of skin care products and increased awareness of natural acne medications which propelled the demand for acne medications in this region.

However, Asia Pacific is expected to grow rapidly with increasing market size owing to factors such as rising healthcare expenditure and increased demand for acne treatments in developing countries in the region.

Competitive landscape

Maximum growth opportunities make the acne medication market highly competitive. Some of the major market players are Almirall SA., Bausch Health Companies Inc., Galderma SA, Mayne Pharma Group Limited, GlaxoSmithKline Plc (GSK), Mylan NV, Pfizer Inc., Johnson & Johnson, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries ltd. and many others.

Several development strategies have been adopted by companies in recent years. For example, in June 2020Bausch Health Companies Inc. and Ortho Dermatologics, announced that ARAZLO (tazarotene) Lotion is commercially available to healthcare professionals across the United States. ARAZLO is the tazarotene acne treatment medication available as a lotion.

Also in February 2020, Almirall, SA (ALM) announced the development of Seysara (sarecycline), the advanced oral tetracycline-derived antibiotic for the treatment of inflammatory lesions in moderate to severe non-nodular acne vulgaris. The product is expected to be submitted to the National Medical Products Administration (NMPA) in 2023.

Market dynamics


  • Unhealthy eating habits and increased sedentary lifestyles

  • Presence of acne vulgaris in adolescents and adults

  • Growing awareness of general appearance, health and dress



Companies cited

  • Almirall SA.

  • Bausch Health Companies Inc.

  • Galderma SA

  • Mayne Pharma Group Limited

  • GlaxoSmithKline Plc (GSK)

  • Mylan NV, Pfizer Inc.

  • Johnson & Johnson

  • Sun Pharmaceutical Industries Limited

  • Teva Pharmaceutical Industries Ltd.

Report scope

Global Acne Drugs Market – By Therapeutic Class

  • Retinoids

  • Topical and combination retinoids

  • Oral retinoid (isotretinoin)

  • Antibiotics

  • Topical and combination antibiotics

  • Oral antibiotics

  • Benzoyl peroxide

  • Salicylic acid

  • Others

Global Acne Drugs Market – By Formulation

  • Topical medications

  • Oral medications

Global Acne Drugs Market – By Type

Global Acne Drugs Market – By Acne Type

  • Non-inflammatory acne

  • Inflammatory acne

Global Acne Drugs Market – By Distribution Channel

  • Retail stores

  • E-commerce

  • Pharmacies and drugstores

Global Acne Drugs Market – By Geography

  • North America

  • WE

  • Canada

  • Mexico

  • Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Rest of Europe

  • Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

  • Rest of Asia Pacific

  • Line

  • Brazil

  • Saudi Arabia

  • South Africa

  • Remaining countries

For more information about this report visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716




View original content:–2030-featuring-almirall-bausch-galderma-mayne-pharma-glaxosmithkline- mylan-pfizer-johnson–johnson-sun-pharma–teva-301649462.html

SOURCE Research and Markets

About Michael Bill

Check Also

Supply chain disruptions forced 60% of rheumatologists to replace drugs

November 03, 2022 2 minute read ADD A SUBJECT TO EMAIL ALERTS Receive an email …